(Q43992557)

English

Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the Europea

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24419525%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24419525%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24419525%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Charles Craddock

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24419525%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24419525%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

F Baron

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24419525%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

M Labopin

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24419525%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

D Blaise

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24419525%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

L Lopez-Corral

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24419525%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

S Vigouroux

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24419525%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

P Jindra

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24419525%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

H Goker

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24419525%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

G Socié

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24419525%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

P Chevallier

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24419525%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

A Sandstedt

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24419525%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

R F Duarte

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24419525%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

A Nagler

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24419525%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

M Mohty

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24419525%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

language of work or name

0 references

publication date

13 January 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24419525%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24419525%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

49

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24419525%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24419525%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

389-396

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24419525%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

The role of in vivo T-cell depletion on reduced-intensity conditioning allogeneic stem cell transplantation from HLA-identical siblings in patients with follicular lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peripheral-blood stem cells versus bone marrow from unrelated donors

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Azacitidine after allo-SCT: the good without the bad?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High alloreactivity of low-dose prophylactic donor lymphocyte infusion in patients with acute leukemia undergoing allogeneic hematopoietic cell transplantation with an alemtuzumab-containing conditioning regimen.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced intensity conditioning for allogeneic hematopoietic cell transplantation: current perspectives

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mobilized peripheral blood stem cells compared with bone marrow as the stem cell source for unrelated donor allogeneic transplantation with reduced-intensity conditioning in patients with acute myeloid leukemia in complete remission: an analysis fro

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome of donor lymphocyte infusion after T cell-depleted allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

What is the role for donor natural killer cells after nonmyeloablative conditioning?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of center experience on results of reduced intensity: allogeneic hematopoietic SCT for AML. An analysis from the Acute Leukemia Working Party of the EBMT.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hematopoietic cell transplantation after reduced-intensity conditioning for older adults with acute myeloid leukemia in complete remission

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCT

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of cytogenetics risk on outcome after reduced intensity conditioning allo-SCT from an HLA-identical sibling for patients with AML in first CR: a report from the acute leukemia working party of EBMT.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term outcome of unrelated donor transplantation for AML using myeloablative conditioning incorporating pretransplant Alemtuzumab

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Graft-versus-host disease induced graft-versus-leukemia effect: greater impact on relapse and disease-free survival after reduced intensity conditioning

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two days of antithymocyte globulin are associated with a reduced incidence of acute and chronic graft-versus-host disease in reduced-intensity conditioning transplantation for hematologic diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/24419525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of Human Development Index with rates and outcomes of hematopoietic stem cell transplantation for patients with acute leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.204

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/BMT.2013.204

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24419525%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24419525%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43992557&oldid=2206376189"